Stock Events

Stock Events

CapForce 

$2.02
0
+$0.02+1% Thursday 16:15

Statistics

Day High
3.5
Day Low
3
52W High
34
52W Low
0.0001
Volume
421
Avg. Volume
-
Mkt Cap
0
P/E Ratio
0.87
Dividend Yield
-
Dividend
-

Upcoming

Earnings

14AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-1.6
-1.53
-1.47
-1.4
Expected EPS
N/A
Actual EPS
N/A

Financials

218.55%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
10.39MRevenue
22.71MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CFOR. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap17.47B
Guardant Health, Inc. specializes in liquid biopsies and cancer diagnostics, directly competing with Opgen's diagnostic solutions for detecting pathogens and antibiotic resistance genes.
Illumina
ILMN
Mkt Cap24.5B
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis, competing in the broader market of genomic analysis where Opgen also operates.
Qiagen NV
QGEN
Mkt Cap7.62B
Qiagen N.V. offers sample to insight solutions including infectious disease diagnostics, directly competing with Opgen's focus on molecular diagnostics.
Thermo Fisher Scientific
TMO
Mkt Cap172.66B
Thermo Fisher Scientific Inc. offers a wide range of diagnostics and research solutions, including those for infectious disease, competing with Opgen's diagnostic products.
Pacific Biosciences of California
PACB
Mkt Cap434.84M
Pacific Biosciences of California, Inc. provides sequencing systems that compete with Opgen's genomic analysis technologies.
Intellia Therapeutics
NTLA
Mkt Cap2.19B
Intellia Therapeutics, Inc. is involved in CRISPR technology for genetic editing, which could compete with Opgen's genomic approaches for diagnostics and treatment.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.57B
BioMarin Pharmaceutical Inc. develops and commercializes innovative biopharmaceuticals, potentially competing with Opgen's treatments and diagnostics in genetic diseases.
Adaptive Biotechnologies
ADPT
Mkt Cap2.81B
Adaptive Biotechnologies Corp. focuses on the immune-driven medicine space, including diagnostics that could compete with Opgen's offerings in infection and resistance detection.

About

CapForce Inc. is a precision medicine company dedicated to developing and commercializing sophisticated molecular microbiology solutions. Its mission is to address life-threatening infectious diseases for patients in the United States and across international markets. The company's diverse product range includes Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel diagnostic tests, and SARS CoV-2 testing kits. Beyond its product line, CapForce extends its offerings to include laboratory services, collaboration services (such as funded software arrangements), and licensing agreements. Additionally, the company provides listing sponsorship and consultancy services. Formerly known as OpGen, Inc., the entity officially changed its name to CapForce Inc. in February 2026. CapForce Inc. was established in 2001 and maintains its headquarters in Clarksburg, Maryland.
Show more...
CEO
Mr. Christian-Laurent Benoit Bonte
Employees
4
Country
United States
ISIN
US68373L5057

Listings

MU
DE
650.MU
LSE
GB
0A8L.LSE
OTC Link
US
CFOR

0 Comments

Share your thoughts

FAQ

What is CapForce stock price today?▼
The current price of CFOR is $2.02 USD — it has increased by +1% in the past 24 hours. Watch CapForce stock price performance more closely on the chart.
What is CapForce stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange CapForce stocks are traded under the ticker CFOR.
Is CapForce stock price growing?▼
CFOR stock has risen by +75% compared to the previous week, the month change is a +133.33% rise, over the last year CapForce has showed a -28.28% decrease.
When is the next CapForce earnings date?▼
CapForce is going to release the next earnings report on August 14, 2026.
What is CapForce revenue for the last year?▼
CapForce revenue for the last year amounts to 10.39M USD.
What is CapForce net income for the last year?▼
CFOR net income for the last year is 22.71M USD.
How many employees does CapForce have?▼
As of June 22, 2026, the company has 4 employees.
In which sector is CapForce located?▼
CapForce operates in the Other sector.
When did CapForce complete a stock split?▼
CapForce has not had any recent stock splits.
Where is CapForce headquartered?▼
CapForce is headquartered in Clarksburg, United States.